Palladium Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$36.6M Sell
206,397
-623
-0.3% -$106K 1.6% 12
2021
Q4
$35.4M Sell
207,020
-389
-0.2% -$63.7K 1.45% 14
2021
Q3
$33.5M Buy
207,409
+1,085
+0.5% +$185K 1.53% 14
2021
Q2
$34M Sell
206,324
-1,750
-0.8% -$290K 1.6% 14
2021
Q1
$34.2M Buy
208,074
+1,205
+0.6% +$195K 1.7% 14
2020
Q4
$32.6M Buy
206,869
+1,112
+0.5% +$164K 1.8% 13
2020
Q3
$30.6M Sell
205,757
-638
-0.3% -$94.4K 1.93% 9
2020
Q2
$29M Buy
206,395
+2,997
+1% +$437K 1.99% 11
2020
Q1
$26.7M Buy
203,398
+4,065
+2% +$577K 2.22% 9
2019
Q4
$29.1M Sell
199,333
-8,993
-4% -$1.22M 1.87% 12
2019
Q3
$28.8M Buy
208,326
+4,205
+2% +$554K 2.01% 9
2019
Q2
$28.4M Buy
204,121
+117
+0.1% +$16.2K 1.97% 11
2019
Q1
$28.5M Buy
204,004
+665
+0.3% +$89.1K 2.05% 10
2018
Q4
$26.2M Sell
203,339
-6,138
-3% -$856K 2.1% 10
2018
Q3
$28.9M Buy
209,477
+3,948
+2% +$525K 1.97% 9
2018
Q2
$24.9M Buy
205,529
+38,891
+23% +$4.85M 1.81% 12
2018
Q1
$21.4M Sell
166,638
-458
-0.3% -$61.9K 1.58% 14
2017
Q4
$23.3M Sell
167,096
-3,448
-2% -$480K 1.69% 12
2017
Q3
$22.2M Sell
170,544
-3,696
-2% -$490K 1.69% 13
2017
Q2
$23.1M Sell
174,240
-2,776
-2% -$354K 1.82% 13
2017
Q1
$22M Sell
177,016
-4,686
-3% -$560K 1.78% 14
2016
Q4
$20.9M Sell
181,702
-66,573
-27% -$7.69M 1.77% 15
2016
Q3
$29.3M Buy
248,275
+1,681
+0.7% +$204K 2.56% 3
2016
Q2
$29.9M Buy
246,594
+2,247
+0.9% +$255K 2.72% 3
2016
Q1
$26.4M Buy
244,347
+71,936
+42% +$7.45M 2.43% 5
2015
Q4
$17.7M Sell
172,411
-1,390
-0.8% -$140K 1.64% 16
2015
Q3
$16.2M Sell
173,801
-2,717
-2% -$263K 1.6% 15
2015
Q2
$17.2M Sell
176,518
-5,586
-3% -$559K 1.54% 14
2015
Q1
$18.3M Sell
182,104
-3,216
-2% -$327K 1.57% 15
2014
Q4
$19.4M Buy
185,320
+191
+0.1% +$20.1K 1.68% 13
2014
Q3
$19.7M Sell
185,129
-8,663
-4% -$898K 1.77% 10
2014
Q2
$20.3M Sell
193,792
-52,877
-21% -$5.34M 1.8% 11
2014
Q1
$24.2M Sell
246,669
-1,694
-0.7% -$157K 2.22% 4
2013
Q4
$22.7M Sell
248,363
-2,857
-1% -$263K 2.16% 5
2013
Q3
$21.8M Buy
251,220
+3,590
+1% +$322K 2.21% 5
2013
Q2
$21.3M Buy
+247,630
New +$21M 2.24% 5

Other funds holding JNJ

Palladium Partners's JNJ Position: Q1 2022 in Review

Palladium Partners reduced its Johnson & Johnson (JNJ) stake by 0.3% in Q1 2022, selling an estimated $106K and leaving 206,397 shares worth $36.6M. The position accounts for 1.6% of the portfolio, ranked #12.

Palladium Partners first reported a position in JNJ in Q2 2013 and has held it in 36 quarters since. 3,677 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

  • Palladium Partners held 206,397 shares of Johnson & Johnson worth $36.6M as of Q1 2022.
  • Palladium Partners sold 623 Johnson & Johnson shares in Q1 2022, an estimated $106K.
  • Johnson & Johnson made up 1.6% of Palladium Partners's portfolio in Q1 2022, its #12 holding.
  • Palladium Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 36 quarters since.
  • 3,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.